Article Data

  • Views 557
  • Dowloads 136

Original Research

Open Access

Time since first sexual intercourse is a good parameter to select women at higher risk for CIN3

  • A.M. Dias Fachini1
  • M.G. Discacciati1
  • C.A. Scheler de Souza1
  • S.M. Bergo1
  • M. Traue1
  • L. de Ângelo Andrade1
  • M.T. Lima1
  • L.C. Zeferino1,*,

1State University of Campinas, Sao Paulo, Brazil

DOI: 10.12892/ejgo4003.2018 Vol.39,Issue 3,June 2018 pp.433-436

Published: 10 June 2018

*Corresponding Author(s): L.C. Zeferino E-mail: zeferino@fcm.unicamp.br

Abstract

Objectives: Low-grade squamous intraepithelial lesion (LSIL) shows higher prevalence in young women, when human papillomavirus (HPV) testing has no consistent role for colposcopy triage. Some women with LSIL may reveal cervical intraepithelial neoplasia grade 2 (CIN2) or grade 3 (CIN3) and, therefore, could be clinically relevant to identify those who are at higher risk for this outcome. This study aimed to evaluate the association of some factors with the histological outcome of women showing cytological LSIL at cervical cancer screening. Materials and Methods: This study included 791 women with cytological LSIL who were referred for immediate colposcopy. Results: higher time since first sexual intercourse (TFI) and non-compliance in the screening were associated with higher prevalence rate for CIN3. Multivariate analysis showed that the CIN3 outcome was associated with TFI ≥10 years considering as a reference < 4 years (odds ratio (OR), 11.11; 95% confidence interval (CI), 2.04–50.00) and 5–9 years (OR, 11.09; 95% CI, 2.04–50.00), and it showed borderline association with non-compliance in screening (OR, 2.48; 95% CI, 0.99–6.17). The age of first sexual intercourse (AFI) was not associated with CIN3 outcome. Conclusions:Women showing LSIL in screening have higher probability to reveal CIN3 if the TFI is ten or more years ago and when they are noncompliant with cervical cancer screening. These women should have immediate colposcopy. These findings presented the question of which parameter is better to define when the woman should begin screening for cervical cancer, age or time since the first sexual intercourse. This study showed that the second parameter could perform better.

Keywords

Low-grade squamous intraepithelial lesion; Human papillomavirus; Screening; Time of first sexual intercourse.

Cite and Share

A.M. Dias Fachini,M.G. Discacciati,C.A. Scheler de Souza,S.M. Bergo,M. Traue,L. de Ângelo Andrade,M.T. Lima,L.C. Zeferino. Time since first sexual intercourse is a good parameter to select women at higher risk for CIN3. European Journal of Gynaecological Oncology. 2018. 39(3);433-436.

References

[1] Doorbar J., Quint W., Banks L., Bravo I.G., Stoler M., Broker T.R., et al.: “The biology and life-cycle of human papillomaviruses”. Vaccine, 2012, 30, F55.

[2] Snijders P.J., Steenbergen R.D., Heideman D.A., Meijer C.J.: “HPVmediated cervical carcinogenesis: concepts and clinical implications”. J. Pathol., 2006, 208, 152.

[3] Doorbar J., Egawa N., Griffin H., Kranjec C., Murakami I.: “Human papillomavirus molecular biology and disease association”. Rev. Med. Virol., 2015, 25, 2.

[4] Castle P.E., Gage J.C., Wheeler C.M., Schiffman M.: “The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy”. Obstet. Gynecol., 2011, 118, 1222.

[5] Berkowitz R.P.: “2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors”. Obstet Gynecol., 2013, 122, 393.

[6] Wright T.C., Massad L.S., Dunton C.J., Spitzer M., Wilkinson E.J., Solomon D., et al.: “2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests”. Am. J. Obstet. Gynecol., 2007, 197, 346.

[7] Bentley J., Colposcopists SoC.: “Colposcopic management of abnormal cervical cytology and histology”. J. Obstet. Gynaecol. Can., 2012, 34, 1188.

[8] Albrow R., Kitchener H., Gupta N., Desai M.: “Cervical screening in England: the past, present, and future”. Cancer Cytopathol., 2012, 120, 87.

[9] Group A-LTSA: “Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance”. Am. J. Obstet. Gynecol., 2003, 188, 1383.

[10] Garrett L.A., McCann C.K.: “Abnormal cytology in 2012: management of atypical squamous cells, low-grade intraepithelial neoplasia, and high-grade intraepithelial neoplasia”. Clin. Obstet. Gynecol.,

2013, 56, 25.

[11] Schiffman M., Solomon D.: “Findings to date from the ASCUS-LSIL Triage Study (ALTS)”. Arch. Pathol. Lab. Med., 2003, 127, 946.

[12] Arbyn M., Roelens J., Simoens C., Buntinx F., Paraskevaidis E., Martin-Hirsch P.P., et al.: “Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions”. Cochrane Database Syst. Rev., 2013, 3, CD008054.

[13] Cancer ICoESoC: “Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies”. Cancer Epidemiol. Biomarkers Prev., 2009, 18, 1060.

[14] Plummer M., Peto J., Franceschi S., Cancer ICoESoC: “Time since first sexual intercourse and the risk of cervical cancer”. Int. J. Cancer, 2012, 130, 2638.

[15] Jordan J., Arbyn M., Martin-Hirsch P., Schenck U., Baldauf J.J., Da Silva D., et al.: “European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1”. Cytopathology, 2008, 19, 342.

[16] Elit L., Levine M.N., Julian J.A., Sellors J.W., Lytwyn A., Chong S., et al.: “Expectant management versus immediate treatment for lowgrade cervical intraepithelial neoplasia: a randomized trial in Canada and Brazil”. Cancer, 2011, 117, 1438.

[17] Winer R.L., Kiviat N.B., Hughes J.P., Adam D.E., Lee S.K., Kuypers J.M., et al.: “Development and duration of human papillomavirus lesions, after initial infection”. J. Infect. Dis., 2005, 191, 731.

[18] Schiffman M., Wentzensen N., Wacholder S., Kinney W., Gage J.C., Castle P.E.: “Human papillomavirus testing in the prevention of cervical cancer”. J. Natl. Cancer Inst., 2011, 103, 368.

[19] Castellsagué X., Paavonen J., Jaisamrarn U., Wheeler C.M., Skinner S.R., Lehtinen M., et al.: “Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial”. BMC Infect Dis., 2014, 14, 551.

[20] Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J., et al.: “American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer”. Am. J. Clin. Pathol., 2012, 137, 516.

[21] Discacciati M.G., de Souza C.A., d’Otavianno M.G., Ângelo-Andrade L.A., Westin M.C., Rabelo-Santos S.H., et al.: “Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2011, 155, 204.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top